Related Experiment Video
Updated: Aug 26, 2026

A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
Addressing the burden of group A streptococcal disease in India
1Department of Pediatrics, WHO, Collaborating Center for Reference and Research on Streptococci, University of Minnesota Medical School, Minneapolis 55455, USA.
Abstract:
Group A streptococcus-associated disease and sequelae continue to have devastating effects on public health and national economy as they mainly affect children and young adults. There is an urgent need for wider application of methods of primary prevention, in the form of optimal diagnosis and management of the simple group A streptococcal sore throat. This review article briefly summarizes the burden of streptococcal disease in India, and discusses treatment options standardized by the World Health Organization. Penicillin continues to remain the drug of choice for treating group A streptococcal pharyngitis and for prevention of acute rheumatic fever in non-allergic patients. Also discussed in this review are contemporary thoughts on streptococcal "carriers", recurrent infections, antibiotic treatment "failures" and emergence of drug resistance among group A streptococci.
Related Concept Videos
Streptococcal Pharyngitis
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease III: Medical Management
Bacterial Meningitis I: Introduction
Infectious Diseases and Their Occurrence
Bacterial Meningitis